Our research shows that high levels of tocotrienols in the breast were associated with lower incidence of breast cancer. Oral administration of tocotrienols however ends up with poor uptake into the blood. We have therefore developed an alternative method of delivering tocotrienols to the breast via transdermal application.

Main Research: Dr. Kalanithi Nesaretnam